Insiders have been given themselves shares for a long time. What we have been saying about this setup is those “investors “ in the offering are not locked up. They buy at 4 sell at 7-8. The selling pressure will sink the pps how far I don’t know but as student pointed out the whole idea of the offering is to raise a few bucks to get the drug to trial and uplist.
Why do you think the pps will not collapse post RS? I’m looking for anything positive
Agree. I am a big critic of the company but these S1 terms are fairly standard and actually better than many OTC stocks trying to do the same thing that I have seen. I see no problem with it.
In fact I have seen many otc companies having to let shares be given away to investors at .001 when the stock is at .05 or more. So the fact that this is at .01 with no warrants? Again no warrants....I think that is EXTREMELY FAIR to all. That is not a critique worth anything here.
I can only hazard a guess that since CUBT looks as though they have this S1 ready to go and getting approved? That their drug pipeline and future plans are in agreement with the investors that they have lined up.
I am not saying that this stock should be at 20 cents right now, but based on the OS and the potential revs that 'could happen'? A 6 cent valuation is very reasonable. Which only gives this a $45 M valuation. Which is very very fair considering the drug potential.
News 
Market Data 
Discover 
